Pneumonia Vaccine Market Report

Global Pneumonia Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 27, 2022
  • PAGES：193
  • REPORT CODE：GMM816188
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pneumonia Vaccine market report explains the definition, types, applications, major countries, and major players of the Pneumonia Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Emergent Biosolutions

    • Pfizer Inc

    • Merck & Co Inc

    • Johnson & Johnson

    • Astellas Pharma Inc

    • Sanofi Pasteur

    • Astrazeneca Plc

    • CSL Limited

    • Glaxosmithkline Plc

    • Serum Institute of India Pvt Ltd

    By Type:

    • Pneumococcal Conjugate Vaccine (PCV13)

    • Pneumococcal Polysaccharide Vaccine (PPSV23)

    By End-User:

    • Pneumonia

    • Meningitis

    • Sepsis

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pneumonia Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pneumonia Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Pneumonia Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pneumonia Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pneumonia Vaccine Market- Recent Developments

    • 6.1 Pneumonia Vaccine Market News and Developments

    • 6.2 Pneumonia Vaccine Market Deals Landscape

    7 Pneumonia Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Pneumonia Vaccine Key Raw Materials

    • 7.2 Pneumonia Vaccine Price Trend of Key Raw Materials

    • 7.3 Pneumonia Vaccine Key Suppliers of Raw Materials

    • 7.4 Pneumonia Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Pneumonia Vaccine Cost Structure Analysis

      • 7.5.1 Pneumonia Vaccine Raw Materials Analysis

      • 7.5.2 Pneumonia Vaccine Labor Cost Analysis

      • 7.5.3 Pneumonia Vaccine Manufacturing Expenses Analysis

    8 Global Pneumonia Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pneumonia Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pneumonia Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pneumonia Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pneumonia Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Pneumococcal Conjugate Vaccine (PCV13) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pneumonia Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pneumonia Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Meningitis Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Sepsis Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pneumonia Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Pneumonia Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pneumonia Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Pneumonia Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Pneumonia Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.2 UK Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.5 France Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Pneumonia Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Pneumonia Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.3 India Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Pneumonia Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Pneumonia Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pneumonia Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Pneumonia Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pneumonia Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Pneumonia Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Pneumonia Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Pneumonia Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pneumonia Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pneumonia Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pneumonia Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Pneumonia Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Pneumonia Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Pneumonia Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pneumonia Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Pneumonia Vaccine Consumption (2017-2022)

    11 Global Pneumonia Vaccine Competitive Analysis

    • 11.1 Emergent Biosolutions

      • 11.1.1 Emergent Biosolutions Company Details

      • 11.1.2 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Emergent Biosolutions Pneumonia Vaccine Main Business and Markets Served

      • 11.1.4 Emergent Biosolutions Pneumonia Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer Inc

      • 11.2.1 Pfizer Inc Company Details

      • 11.2.2 Pfizer Inc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Inc Pneumonia Vaccine Main Business and Markets Served

      • 11.2.4 Pfizer Inc Pneumonia Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Merck & Co Inc

      • 11.3.1 Merck & Co Inc Company Details

      • 11.3.2 Merck & Co Inc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Merck & Co Inc Pneumonia Vaccine Main Business and Markets Served

      • 11.3.4 Merck & Co Inc Pneumonia Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Johnson & Johnson

      • 11.4.1 Johnson & Johnson Company Details

      • 11.4.2 Johnson & Johnson Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Johnson & Johnson Pneumonia Vaccine Main Business and Markets Served

      • 11.4.4 Johnson & Johnson Pneumonia Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Astellas Pharma Inc

      • 11.5.1 Astellas Pharma Inc Company Details

      • 11.5.2 Astellas Pharma Inc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Astellas Pharma Inc Pneumonia Vaccine Main Business and Markets Served

      • 11.5.4 Astellas Pharma Inc Pneumonia Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Sanofi Pasteur

      • 11.6.1 Sanofi Pasteur Company Details

      • 11.6.2 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Sanofi Pasteur Pneumonia Vaccine Main Business and Markets Served

      • 11.6.4 Sanofi Pasteur Pneumonia Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Astrazeneca Plc

      • 11.7.1 Astrazeneca Plc Company Details

      • 11.7.2 Astrazeneca Plc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Astrazeneca Plc Pneumonia Vaccine Main Business and Markets Served

      • 11.7.4 Astrazeneca Plc Pneumonia Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 CSL Limited

      • 11.8.1 CSL Limited Company Details

      • 11.8.2 CSL Limited Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 CSL Limited Pneumonia Vaccine Main Business and Markets Served

      • 11.8.4 CSL Limited Pneumonia Vaccine Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Glaxosmithkline Plc

      • 11.9.1 Glaxosmithkline Plc Company Details

      • 11.9.2 Glaxosmithkline Plc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Glaxosmithkline Plc Pneumonia Vaccine Main Business and Markets Served

      • 11.9.4 Glaxosmithkline Plc Pneumonia Vaccine Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Serum Institute of India Pvt Ltd

      • 11.10.1 Serum Institute of India Pvt Ltd Company Details

      • 11.10.2 Serum Institute of India Pvt Ltd Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Serum Institute of India Pvt Ltd Pneumonia Vaccine Main Business and Markets Served

      • 11.10.4 Serum Institute of India Pvt Ltd Pneumonia Vaccine Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Pneumonia Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Pneumonia Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Pneumococcal Conjugate Vaccine (PCV13) Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pneumonia Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Sepsis Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pneumonia Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pneumonia Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pneumonia Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pneumonia Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pneumonia Vaccine

    • Figure of Pneumonia Vaccine Picture

    • Table Global Pneumonia Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pneumonia Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Pneumococcal Conjugate Vaccine (PCV13) Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Meningitis Consumption and Growth Rate (2017-2022)

    • Figure Global Sepsis Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumonia Vaccine Consumption by Country (2017-2022)

    • Table North America Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure United States Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure Germany Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure China Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Pneumonia Vaccine Consumption by Country (2017-2022)

    • Figure Australia Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pneumonia Vaccine Consumption and Growth Rate (2017-2022)

    • Table Emergent Biosolutions Company Details

    • Table Emergent Biosolutions Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent Biosolutions Pneumonia Vaccine Main Business and Markets Served

    • Table Emergent Biosolutions Pneumonia Vaccine Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Pneumonia Vaccine Main Business and Markets Served

    • Table Pfizer Inc Pneumonia Vaccine Product Portfolio

    • Table Merck & Co Inc Company Details

    • Table Merck & Co Inc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Pneumonia Vaccine Main Business and Markets Served

    • Table Merck & Co Inc Pneumonia Vaccine Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Pneumonia Vaccine Main Business and Markets Served

    • Table Johnson & Johnson Pneumonia Vaccine Product Portfolio

    • Table Astellas Pharma Inc Company Details

    • Table Astellas Pharma Inc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Pneumonia Vaccine Main Business and Markets Served

    • Table Astellas Pharma Inc Pneumonia Vaccine Product Portfolio

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Pneumonia Vaccine Main Business and Markets Served

    • Table Sanofi Pasteur Pneumonia Vaccine Product Portfolio

    • Table Astrazeneca Plc Company Details

    • Table Astrazeneca Plc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Plc Pneumonia Vaccine Main Business and Markets Served

    • Table Astrazeneca Plc Pneumonia Vaccine Product Portfolio

    • Table CSL Limited Company Details

    • Table CSL Limited Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited Pneumonia Vaccine Main Business and Markets Served

    • Table CSL Limited Pneumonia Vaccine Product Portfolio

    • Table Glaxosmithkline Plc Company Details

    • Table Glaxosmithkline Plc Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline Plc Pneumonia Vaccine Main Business and Markets Served

    • Table Glaxosmithkline Plc Pneumonia Vaccine Product Portfolio

    • Table Serum Institute of India Pvt Ltd Company Details

    • Table Serum Institute of India Pvt Ltd Pneumonia Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd Pneumonia Vaccine Main Business and Markets Served

    • Table Serum Institute of India Pvt Ltd Pneumonia Vaccine Product Portfolio

    • Figure Global Pneumococcal Conjugate Vaccine (PCV13) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningitis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sepsis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pneumonia Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pneumonia Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US